Retavase (Chiesi USA, Inc.)
Welcome to the PulseAid listing for the Retavase drug offered from Chiesi USA, Inc.. This pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Chiesi USA, Inc. |
| NON-PROPRIETARY NAME: | reteplase |
| SUBSTANCE NAME: | |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | |
| ROUTE: | |
| DOSAGE FORM: | KIT |
| MARKETING CATEGORY NAME: | BLA |
| START MARKETING DATE: | 1996-10-30 |
| END MARKETING DATE: | 0000-00-00 |
Retavase HUMAN PRESCRIPTION DRUG Details:
| Item Description | Retavase from Chiesi USA, Inc. |
| LABELER NAME: | Chiesi USA, Inc. |
| DEA SCHEDULE: | |
| ACTIVE STRENGTH: | () |
| START MARKETING DATE: | 1996-10-30 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 10122-141_966dcb73-29d5-4119-ba97-3298e384b83a |
| PRODUCT NDC: | 10122-141 |
| APPLICATION NUMBER: | BLA103786 |